Search
logo
Search
The article is in preview mode

Probiotics recommendations from the AGA and EPA

Homepage Articles Probiotics recommendations from the AGA and EPA

Probiotics recommendations from the AGA and EPA

The American Gastroenterological Association (AGA) has published a practical guide to the use of probiotics in the treatment of gastrointestinal disorders. In 2017, a panel of experts convened by the European Paediatric Association (EPA) summarized the European recommendations for the use in children in specific clinical situations.

Table of Contents

1. Probiotics are a global trend

Probiotics were used by 4 times as many people as in 2007 in the United States in 2015. It is therefore worthwhile to review the latest recommendations summarizing the reliability of the publications so far. The AGA recommendations have different strengths. The quality of the evidence is assessed on a four-step scale (very low, low, medium, high). The recommendation can be conditional or strong. Probiotic as defined by the WHO are living microorganisms that have the appropriate amount of health benefits.

2. Probiotics for the premature

A combination of Lactobacillus spp. and Bifidobacetrium spp is recommended. Such recommendations are supported by evidence of moderate to high quality. This intervention is to prevent the occurrence of deadly inflammation of the intestine. Examples of combinations are given below. Lacto Bacillus rhamnosus GG (ATCC 53103) + Bifitobacterium longum ssp. Infantis; Latobacillus casei + Biffidobacterius breve; ?? Lacto bacillus acidophilus + BiFidobacteria longum sp. Infantes;

3. Bacterial inflammation of the stomach and intestines

The AGA recommends that patients with pancreatic inflammation consider a combination of 8 strains of bacteria, but the quality of the evidence is very low. In children diagnosed with inflammation of the intestine and stomach with a bacterial basis, the AGA does not recommend any probiotics. This allows normal excretion of the stool.

4. It's a childhood illness, IBS

If it is to be used, it should be taken in 108 CFU (colony-forming units) per day for 2130 days. In the case of IBS, the AGA recommendations mention that studies have shown some strains to be effective but have been carried out in small groups. Particular caution should be exercised in the use of probiotics by people with weakened immunity, who have a short bowel syndrome, who are undergoing treatment for cancer.

The author of the article is Dietspremium